Stay updated with breaking news from Steven Balk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2021 Class of PCF Team Challenge Award recipients and a total of more than $9 million...
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2021 Class of PCF Team Challenge Award recipients and a total of more than $9 million...
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the Class of 2021 Young Investigator Award recipients totaling nearly $6.5 million in...
Study: A subset of patients with localized prostate cancer may benefit from immunotherapies In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors. Prostate cancer, however, is considered a "cold" tumor, with few immune cells recognizing and infiltrating prostate malignancies. Accordingly, prostate cancer has been found to respond poorly to the class of immunotherapies known as immune checkpoint inhibitors. In previous work, a team ...